Paid Clinical Trials for Colorectal Cancer

Showing 21 – 40 of 103 results

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

by CTG

in Colorectal Cancer, Gastric Cancer, Neuroendocrine Tumors

Other

Georgia

Deadline:

05/01/2027

FOG-001 in Locally Advanced or Metastatic Solid Tumors

by CTG

in Cancer, Colorectal Cancer, Metastatic Cancer, Solid Tumor, Locally Advanced Solid Tumor

Other

Arizona

Deadline:

08/31/2027

Precise Oncology Interventions in Nutrition and Training (OnPoint)

by CTG

in Breast Cancer, Prostate Cancer, Colorectal Cancer

Other

Florida

Deadline:

09/30/2027

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

by CTG

in Colorectal Cancer, Minimal Residual Disease, Adjuvant Chemotherapy, Fruquintinib, Tislelizumab

Other

Texas

Deadline:

04/01/2028

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

by CTG

in Breast Cancer, Cancer, Colorectal Cancer

Other

North Carolina

Deadline:

05/01/2026

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

by CTG

in Colorectal Cancer, Minimal Residual Disease

Other

Texas

Deadline:

01/18/2029

Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)

by CTG

in Colorectal Cancer

Other

Arizona

Deadline:

12/01/2028

Colorectal Cancer Awareness, Research and Education and Screening – Rural Expansion, Access and Capacity for Health

by CTG

in Colorectal Cancer

Other

Florida

Deadline:

12/01/2027

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

by CTG

in Colorectal Cancer, Pancreatic Cancer

Other

Maryland

Deadline:

07/01/2029

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

by CTG

in Colorectal Cancer

Other

Illinois

Deadline:

07/01/2027

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

by CTG

in Colorectal Cancer

Other

Texas

Deadline:

12/22/2028

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

by CTG

in Colorectal Cancer, Colorectal Cancer Metastatic

Other

California

Deadline:

06/21/2026

Improving Care After Inherited Cancer Testing

by CTG

in Breast Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Inherited Cancer Syndrome

Other

Tennessee

Deadline:

12/01/2028

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

by CTG

in Colorectal Cancer

Other

Arizona

Deadline:

10/01/2028

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

by CTG

in Cancer, Colorectal Cancer, Solid Tumor, Adult, NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung

Other

Arizona

Deadline:

03/31/2030

A Randomised Controlled Trial to Evaluate the Impact of Complement Theory’s Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors’ Quality of Life

by CTG

in Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Other Cancer

Other

Delaware

Deadline:

02/28/2026

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

by CTG

in Breast Cancer, Cervical Cancer, Endometrial Cancer, Colorectal Cancer, Bladder Cancer

Other

Wisconsin

Deadline:

12/01/2026

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

by CTG

in Colorectal Cancer, Regorafenib, High Risk Patients

Other

Texas

Deadline:

05/01/2029

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

by CTG

in Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancers, Ovarian Cancers

Other

Michigan

Deadline:

08/01/2029

Colorectal Cancer Screening in Cystic Fibrosis

by CTG

in Colorectal Cancer, Cystic Fibrosis, Adenoma

Other

California

Deadline:

06/30/2026

Load more All clinical trials loaded.

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Precise Oncology Interventions in Nutrition and Training (OnPoint)

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)

Colorectal Cancer Awareness, Research and Education and Screening – Rural Expansion, Access and Capacity for Health

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A Randomised Controlled Trial to Evaluate the Impact of Complement Theory’s Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors’ Quality of Life

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Colorectal Cancer Screening in Cystic Fibrosis

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Colorectal Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps